Top compounds associated with response to ITGAD


Feature Type Standardized
Nominal ANOVA
mRNA Vinblastine GDSC1000 pan-cancer AAC 0.049 0.1
mRNA Methotrexate GDSC1000 pan-cancer AAC 0.042 0.1
mRNA Cetuximab GDSC1000 pan-cancer AAC 0.047 0.1
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.052 0.1
mRNA GW843682X GDSC1000 pan-cancer AAC -0.073 0.1
mRNA SJ-172550 CTRPv2 pan-cancer AAC 0.054 0.1
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.049 0.2
mRNA vincristine CTRPv2 pan-cancer AAC -0.042 0.2
mRNA isoliquiritigenin CTRPv2 pan-cancer AAC -0.092 0.2
mRNA TAE684 CCLE pan-cancer AAC -0.062 0.2
Download CSV